Skip to main content
OpenTrials

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

495 public trials 78 recruiting studies
Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Active, not recruiting

A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

NCT06821542

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Medical University of Graz Graz, Austria
  • Medizinische Universitaet Innsbruck - Universitaetsklinik Fuer Innere Medizin Iii Innsbruck, Austria
  • Krankenhaus Der Elisabethinen Linz Gmbh Linz, Austria
  • Medizinische Universitat Wien, Universitatsklinik Fur Innere Medizin I Vienna, Austria
View all 130 locations
View Trial Details
Active, not recruiting

A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD

NCT06843408

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Peking University People'S Hospital Beijing, China
  • West China Hospital of Sichuan University Chengdu, China
  • The Second Affiliated Hospital, Army Medical University (Xinqiao Hospital) Chongoing, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, China
View Trial Details
Active, not recruiting

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

NCT05250037

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +14 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions